IP & Technology Law Trends
All Articles
USPTO Provides Further Relief to Patent and Trademark Applicants In Response to the Continuing COVID-19 Pandemic
Jun 01, 2020
|
As a further update to our earlier posts (U.S. Patent and Trademark Office Increases Extensions to Deadlines under the CARES Act; How the USPTO is Responding to the Coronavirus Outbreak; and USPTO and Copyright Office Announce Extensions to Deadlines...
Continue Reading >
An Important Option to Consider for Filing Patent Applications in the COVID-19 Era
We may be living in uncertain times right now but that does not mean the end of technological innovations. In fact, many individuals, companies, and even entire industries are innovating more than ever now—intentionally or not—as they strive to adapt...
Continue Reading >
U.S. Patent and Trademark Office Increases Extensions to Deadlines under the CARES Act
Apr 29, 2020
|
As a further update to earlier posts regarding recent actions taken by the United States Patent and Trademark Office (USPTO) due to the COVID-19 pandemic, the USPTO announced this week an increased extension of time for the filing of various pat...
Continue Reading >
Supreme Court Reinforces Position That the Patent Office Has the Final Say on Whether to Initiate an Inter Partes Review
On April 20, 2020, the U.S. Supreme Court decided that the USPTO’s decision to institute inter partes review, even after the one-year statutory time limit for requesting the review, is not appealable. In other words, the USPTO has the final say for a...
Continue Reading >
USPTO and Copyright Office Announce Extensions to Deadlines Under the CARES Act
Apr 01, 2020
|
|
As an update to our earlier post regarding deadlines and operation of the United States Patent and Trademark Office (USPTO) during the ongoing COVID-19 situation, the USPTO under the authority of the CARES Act announced extensions to the time allowed...
Continue Reading >
How Patent Offices Outside the United States Are Responding to the COVID-19 Pandemic
Mar 31, 2020
|
It has been more than two weeks since the United States Patent and Trademark Office issued a formal response to the COVID-19 pandemic announcing that certain petition fees could be waived for patent applicants who are personally impacted by the novel...
Continue Reading >
